Genetic disorders of cholesterol biosynthesis in mice and humans

Molecular Genetics and Metabolism

Volumn 74, Issue 1-2, 2001, Pages 105-119

  Nwokoro, Ngozi A ^a   Wassif, Christopher A ^a   Porter, Forbes D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CHOLESTEROL; DESMOSTEROL; MEVALONIC ACID; SQUALENE SYNTHASE;

ACIDURIA; ANIMAL MODEL; AUTOSOMAL RECESSIVE DISORDER; BONE DYSPLASIA; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHONDRODYSPLASIA; CONGENITAL MALFORMATION; GENETIC DISORDER; HUMAN; HYPERIMMUNOGLOBULINEMIA; INBORN ERROR OF METABOLISM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SMITH LEMLI OPITZ SYNDROME;

HYDROPS; LEPIDOPTERA;

EID: 0034793082     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2001.3226     Document Type: Article

References (106)

1. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome
2. The biological synthesis of cholesterol
3. Protein prenylation: Molecular mechanisms and functional consequences
4. Chemical structure of sterols that activate oocyte meiosis
5. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha
6. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae
7. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling
8. Mevalonic aciduria: An inborn error of cholesterol biosynthesis?
9. Mevalonic aciduria - An inborn error of cholesterol and nonsterol isoprene biosynthesis
10. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria
11. Mevalonate kinase deficiency in a dizygotic twin with mild mevalonic aciduria
12. Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis
13. Mevalonate kinase assay using DEAE-cellulose column chromatography for first-trimester prenatal diagnosis and complementation analysis in mevalonic aciduria
14. Molecular basis of classical mevalonic aciduria and the hyperimmunoglobulinaemia D and periodic fever syndrome: High frequency of 3 mutations in the mevalonate kinase gene
15. Decreased plasma ubiquinone-10 concentration in patients with mevalonate kinase deficiency
16. Inborn errors of cholesterol biosynthesis
17. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients
18. Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria
19. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome
20. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome
21. Identification of an active site alanine in mevalonate kinase through characterization of a novel mutation in mevalonate kinase deficiency
22. Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry
23. Biochemical and genetic aspects of mevalonate kinase and its deficiency
24. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome
25. A newly recognized syndrome of multiple congenital anomalies
26. The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia, and unilobular lungs
27. Smith-Lemli-Opitz syndrome-type II: Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality
28. Female external genitalia and mullerian duct derivatives in a 46,XY infant with the Smith-Lemli-Opitz syndrome
29. Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome
30. A new face for an old syndrome
31. Smith-Lemli-Opitz syndrome: A variable clinical and biochemical phenotype
32. Incidence of Smith-Lemli-Opitz syndrome in Slovakia
33. Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada
34. Smith-Lemli-Opitz syndrome: Review and report of two affected siblings
35. Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome
36. Smith-Lemli-Opitz syndrome: Phenotypic extreme with minimal clinical findings
37. The Smith-Lemli-Opitz syndrome
38. Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: Polymerase chain reaction-based assays to simplify genotyping
39. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism
40. Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome
41. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome
42. Preputial gland tumor sterols III: A metabolic path from lanosterol to cholesterol
43. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
44. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome
45. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts
46. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes
47. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes
48. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome
49. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism
50. Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-1G → C is found in over sixty percent of US propositi
51. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome
52. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols
53. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome
54. Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus
55. Low maternal serum oestriol at mid-trimester may indicate a fetal disorder of cholesterol biosynthesis
56. Molecular cloning and expression of the human delta 7-sterol reductase
57. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome
58. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome
59. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene
60. RSH/Smith-Lemli-Opitz syndrome: A multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis
61. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome
62. Frequency and ethnic distribution of the common DHCR7 mutation in the Smith-Lemli-Opitz syndrome
63. Carrier frequencies of DHCR7 mutations in West-Austria indicate that Smith-Lemli-Opitz syndrome is among the most common autosomal recessive disorders
64. Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: Evidence for different origins of common mutations
65. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)
66. Treatment of Smith-Lemli-Opitz syndrome: Results of a multicenter trial
67. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome
68. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome
69. Desmosterolosis: A new inborn error of cholesterol biosynthesis
70. Clinical phenotype of desmosterolosis
71. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay
72. A new autosomal recessive lethal chondrodystrophy with congenital hydrops
73. Greenberg dysplasia: First reported case with additional non-skeletal malformations and without consanguinity
74. Hydrops-ectopic calcification-moth-eaten skeletal dysplasia (Greenberg dysplasia): Prenatal diagnosis and further delineation of a rare genetic disorder
75. Abnormal metabolism of 14-dehydrosterols in hydrops-ectopic calcification-moth-eaten skeletal dysplasia
76. Human lamin B receptor exhibits sterol C14-reductase activity in Saccharomyces cerevisiae
77. X-linked dominant chondrodysplasia punctata. Review of literature and report of a case
78. XXY male with X-linked dominant chondrodysplasia punctata (Happle syndrome)
79. X-linked dominant chondrodysplasia punctata/ichthyosis/cataract syndrome in males
80. The Conradi-Hunermann-Happle syndrome (CDPX2) and emopamil binding protein: Novel mutations, and somatic and gonadal mosaicism
81. Abnormal sterol metabolism in patients with Conradi-Hunermann-Happle syndrome and sporadic lethal chondrodysplasia punctata
82. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast
83. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata
84. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hunermann syndrome
85. The CHILD syndrome. Congenital hemidysplasia with ichthyosiform erythroderma and limb defects
86. The CHILD nevus: A distinct skin disorder
87. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome
88. Transcription mapping in a 700-kb region around the DXS52 locus in Xq28: Isolation of six novel transcripts and a novel ATPase isoform (hPMCA5)
89. CHILD syndrome caused by deficiency of 3beta-hydroxysteroid-delta8, delta7-isomerase
90. Systematized inflammatory epidermal nevus with symmetrical involvement: An unusual case of CHILD syndrome?
91. X-linked dominant Conradi-Hunermann syndrome presenting as congenital erythroderma
92. Differences in left-right axis pathways in mouse and chick: Functions of FGF8 and SHH
93. Embryonic lethality and defective neural tube closure in raice lacking squalene synthase
94. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol
95. Striated, a new sex-linked gene in the house mouse
96. Bare-patches, a new sex-linked gene in the mouse, associated with a high production of XO females. I. A preliminary report of breeding experiments
97. Homologous genes for X-linked chondrodysplasia punctata in man and mouse
98. Genetic mapping of the X-linked dominant mutations striated (Str) and bare patches (Bpa) to a 600-kb region of the mouse X Chromosome: Implications for mapping human disorders in Xq28
99. A comparative transcription map of the murine bare patches (Bpa) and striated (Str) critical regions and human Xq28
100. The gene mutated in bare patches and striated mice encodes a novel 3-beta-hydroxysteroid dehydrogenase
101. Location of tattared (Td)
102. The mouse X-linked developmental mutant, tattered, lies between DXMit55 and Xkh and is associated with hyperkeratinization
103. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome
104. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon2 subunit mutant mice
105. Molecular genetic and gas chromatography-mass spectrometry studies in the Conradi-Huenermann-Happle syndrome; biochemical evidence for somatic and germ line mosaicism